Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Natus Medical Inc    BABY

Delayed Quote. Delayed  - 05/03 09:59:58 pm
31.78 USD   -0.69%
04/28 INVESTGIATION F : BABY) over Possible Wrongdoing
04/23 ATTENTION NATUS : Shareholder Rights Law Firm Johnson & Weaver, LLP ..
04/22 NATUS MEDICAL : Hagens Berman Investigates Natus Medical Inc.’..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Natus Medical : Natus to Present at the Thomas Weisel Partners 2007 Healthcare Conference

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/28/2007 | 02:00pm CEST

Natus Medical Incorporated (Nasdaq:BABY) today announced that Steven J. Murphy, Vice President Finance and Chief Financial Officer of the Company, will make a presentation at the Thomas Weisel Partners 2007 Healthcare Conference. The conference is being held at the Four Seasons Hotel in Boston, Massachusetts. Mr. Murphy is scheduled to present at 2:05 p.m. Eastern Time (11:05 a.m. PT) on Thursday, September 6, 2007.

Investors may listen to the live webcast and view a copy of the slide presentation online via the ?Investors? section of the Company's web site at http://investor.natus.com. The recorded webcast will be accessible online for at least 30 days. Attendance at the Thomas Weisel Partners 2007 Healthcare Conference is by invitation only.

About Natus Medical

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories. Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
Steven J. Murphy, Chief Financial Officer, 650-802-0400
InvestorRelations@Natus.com


© Business Wire 2007
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on NATUS MEDICAL INC
04/28 INVESTGIATION FOR INVESTORS IN SHARE : BABY) over Possible Wrongdoing
04/23 ATTENTION NATUS SHAREHOLDERS : Shareholder Rights Law Firm Johnson & Weaver, LLP..
04/22 NATUS MEDICAL : Hagens Berman Investigates Natus Medical Inc.’s Guidance o..
04/20 NATUS MEDICAL : beats 1Q profit forecasts
04/20 Natus Medical Announces Record First Quarter 2016 Financial Results
04/16 NATUS MEDICAL : NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suff..
04/15 NATUS MEDICAL : Goldberg Law PC Announces an Investigation of Claims against Nat..
04/15 NATUS MEDICAL : Levi & Korsinsky, LLP Announces the Commencement of an Investiga..
04/15 NATUS MEDICAL : Investigation of Natus Medical Inc. Announced by Law Offices of ..
04/07 NATUS MEDICAL : Acquires NeuroQuest
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials